IFFO2: A Potential Drug Target Or Biomarker (G126917)

Target Name: IFFO2

NCBI ID: G126917

IFFO2

Other Name(s): IFFO2_HUMAN | intermediate filament family orphan 2 | Intermediate filament family orphan 2

IFFO2: A Potential Drug Target Or Biomarker

IFFO2 (IFFO2_HUMAN), a protein that is expressed in various tissues throughout the body, including the brain, heart, and muscles, has been identified as a potential drug target or biomarker for various diseases. The protein is a key component of the intercellular framework, known as the cytoskeleton, and is involved in the regulation of cell shape, movement, and signaling.

IFFO2 has been shown to play a crucial role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these processes makes it an attractive target for drug development.

One of the key functions of IFFO2 is its role in the regulation of cell shape and movement. IFFO2 helps to keep cells in a specific shape, known as a \"tubular\" shape, which allows them to efficiently transmit signals between cells. This is important for the proper functioning of many tissues, including the brain and muscles.

IFFO2 is also involved in the regulation of cell movement. It helps to keep cells in place by interacting with a protein called microtubule-associated protein 2 (MAP2), which is also known as tau. MAP2 is a protein that is involved in the regulation of cell shape and movement, and is a key component of the microtubules that organize cells.

IFFO2 has been shown to be involved in the development and progression of various neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells, and the IFFO2 protein has been shown to play a role in the regulation of the brain cells that are responsible for these conditions.

IFFO2 has also been shown to be involved in the regulation of the immune system. It helps to keep immune cells in check, and has been shown to play a role in the development of autoimmune disorders.

In addition to its involvement in neurodegenerative diseases, IFFO2 has also been shown to be involved in the regulation of other conditions, including cancer. It has been shown to play a role in the regulation of cell division and has been shown to be involved in the development of certain types of cancer.

IFFO2 is also a potential biomarker for certain diseases. The levels of IFFO2 in certain types of cancer have been shown to be elevated, and it has been suggested as a potential biomarker for these conditions.

In conclusion, IFFO2 is a protein that is involved in the regulation of cell shape, movement, and signaling. It has been shown to play a crucial role in the development and progression of various diseases, including cancer and neurodegenerative disorders. Its potential as a drug target or biomarker makes it an attractive target for further research and development.

Protein Name: Intermediate Filament Family Orphan 2

The "IFFO2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IFFO2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets